Using Targeted Virotherapy to Treat a Resistant Ewing Sarcoma Model: From the Bedside to the Bench and Back

<table>EWS cell death is assessed quantitatively by trypan blue assay. EWS cells were inoculated with VSVΔM51 at MOI 0.1. Viability of tumor cells at 96 h after infection is less than 10%.</table>

The Scientific World Journal

fig4

Figure 4

Figure 4: Using Targeted Virotherapy to Treat a Resistant Ewing Sarcoma Model: From the Bedside to the Bench and Back 